Russell Investments Group’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-216,189
| Closed | -$39.7M | – | 3316 |
|
|
2021
Q2 | $39.7M | Sell |
216,189
-18,821
| -8% | -$3.23M | 0.07% | 353 |
|
|
2021
Q1 | $35.9M | Sell |
235,010
-40,915
| -15% | -$6.33M | 0.06% | 361 |
|
|
2020
Q4 | $43.1M | Sell |
275,925
-15,351
| -5% | -$1.97M | 0.09% | 270 |
|
|
2020
Q3 | $33.1M | Sell |
291,276
-6,328
| -2% | -$683K | 0.07% | 309 |
|
|
2020
Q2 | $33.3M | Buy |
297,604
+57,191
| +24% | +$6.07M | 0.07% | 290 |
|
|
2020
Q1 | $21.5M | Buy |
240,413
+160,719
| +202% | +$15.8M | 0.06% | 375 |
|
|
2019
Q4 | $8.58M | Buy |
79,694
+5,042
| +7% | +$539K | 0.02% | 922 |
|
|
2019
Q3 | $7.3M | Sell |
74,652
-8,714
| -10% | -$982K | 0.01% | 1006 |
|
|
2019
Q2 | $10.8M | Buy |
83,366
+42,821
| +106% | +$5.52M | 0.02% | 838 |
|
|
2019
Q1 | $5.46M | Sell |
40,545
-14,298
| -26% | -$1.78M | 0.01% | 1193 |
|
|
2018
Q4 | $5.34M | Sell |
54,843
-4,379
| -7% | -$518K | 0.01% | 1116 |
|
|
2018
Q3 | $8.22M | Buy |
59,222
+6,842
| +13% | +$858K | 0.02% | 1030 |
|
|
2018
Q2 | $6.47M | Buy |
52,380
+15,550
| +42% | +$1.82M | 0.01% | 1155 |
|
|
2018
Q1 | $4.08M | Buy |
36,830
+7,476
| +25% | +$894K | 0.01% | 1470 |
|
|
2017
Q4 | $3.53M | Sell |
29,354
-5,524
| -16% | -$673K | 0.01% | 1523 |
|
|
2017
Q3 | $4.89M | Sell |
34,878
-710
| -2% | -$96.5K | 0.01% | 1284 |
|
|
2017
Q2 | $4.33M | Buy |
35,588
+6,438
| +22% | +$749K | 0.01% | 1315 |
|
|
2017
Q1 | $3.54M | Buy |
29,150
+4,665
| +19% | +$601K | 0.01% | 1422 |
|
|
2016
Q4 | $3.02M | Buy |
+24,485
| New | +$3M | 0.01% | 1569 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM